Sponsor:
Cedar Valley Digestive Health Center
Code:
NCT06460038
Conditions
Synucleinopathy
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Tenapanor
Placebo
Brief summary:
Conditions
Synucleinopathy
Parkinson's Disease
Study ID
NCT06460038
Start date
Jan 1, 2025
Status verified date
Feb, 2025
Completion date
Mar, 2027
Anticipated
Primary completion date
Dec, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Tenapanor
placebo comparator: Placebo
Interventions
Tenapanor
Placebo
Primary outcome measure
Central contacts
Locations
Cedar Valley Digestive Health Center
Recruiting
Waterloo, Iowa, United States, 50701
Contacts
Sponsor
Cedar Valley Digestive Health Center
Last update posted
Feb 10, 2025
Last verified
Feb, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-11. This information was provided to ClinicalTrials.gov by Cedar Valley Digestive Health Center on 2025-02-10.